[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

2016 US Ancillary Hospital Locations (ER, OR, ICU, CCU) Diagnostic Testing Market--Emerging Opportunities and Growth Strategies for Instrument and Reagent Suppliers

October 2015 | 973 pages | ID: 24319142506EN
Venture Planning Group

US$ 10,000.00 US$ 12,500.00 -20 %

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This 973-page report contains 153 tables and provides comprehensive analysis of the diagnostic testing markets outside the main hospital laboratory (ERs, ORs, and ICUs). The report includes analysis of the market dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. We trust, this report will help diagnostic products suppliers develop more effective business, R&D and marketing strategies. RationaleThe growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals closer to the patient. Market Segmentation Analysis- Review of the ER, OR and ICU market segments, including their dynamics, trends, structure, size, growth and major suppliers. - Five-year test volume and sales forecasts for chemistry, immunodiagnostic, microbiology, hematology and coagulation procedures by market segment: - Emergency Rooms - Operating/Recovery Suites - ICUs/CCUsand test category: - Routine and Special Chemistry - Microbiology/Infectious Diseases - Hematology - Flow Cytometry - Coagulation - Immunoproteins - Drugs of Abuse - TDM - Endocrine Function - Tumor MarkersSales and Market Share Analysis- Sales and market shares of major reagent and instrument suppliers. Current and Emerging Products- Analysis of over 130 diagnostic procedures. - Review of leading POC chemistry, immunoassay, hematology and coagulation analyzers, both currently marketed and those in development, including their operating characteristics, features and selling prices. Technology Review- Emerging technologies and their applications for POC testing. - Comprehensive listings of companies developing or marketing POC diagnostic technologies and products, by test.

Competitive Assessments

Assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, joint ventures, and new products in R&D. Strategic Recommendations- Specific opportunities for new POC instruments and reagent systems with potentially significant market appeal during the next ten years. - Design criteria for POC testing products. - Alternative business expansion strategies.
  • Potential market entry barriers and risks.

    Methodology

    Thiis report is based on a combination of primary and secondary sources of information, including review of recent technical and business publications, manufacturer product literature, industry analyst reports, and VPGMarketResearch's proprietary data files.

    Contains 973 pages and 153 tables
  • INTRODUCTION

    RATIONALE FOR TESTING DECENTRALIZATION

    1. OVERVIEW
    2. REGULATORY TRENDS
    3. ECONOMIC TRENDS
    4. DEMOGRAPHIC TRENDS
    5. TECHNOLOGICAL TRENDS
    6. SOCIAL TRENDS
    7. QUALITY OF CARE
    8. DEFENSIVE MEDICINE
    9. QUALITY CONTROL ISSUES

    WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW MAJOR ROUTINE CHEMISTRY TESTS

    1. ALBUMIN
    2. ALKALINE PHOSPHATASE
    3. ALT/SGPT
    4. AMMONIA
    5. AMYLASE
    6. AST/SGOT
    7. BILIRUBIN
    8. BLOOD GASES
    9. BLOOD UREA NITROGEN (BUN)
    10. CALCIUM
    11. CHOLESTEROL
    12. CHOLINESTERASE
    13. CREATININE
    14. ELECTROLYTES
      a. Carbon Dioxide/Bicarbonate
      b. Chloride
      c. Potassium
      d. Sodium
    15. FERRATIN
    16. FOLLATE/FOLIC ACID
    17. FRUCTOSAMINE
    18. GAMMA-GLUTAMYL TRANSPEPTIDASE (GGT)
    19. GLUCOSE
    20. HIGH DENSITY LIPOPROTEIN (HDL)
    21. IRON
    22. LACTATE DEHYDROGENASE (LDH)
    23. MAGNESIUM
    24. PHOSPHORUS
    25. PROTEIN
    26. TRIGLYCERIDES
    27. TROPONIN
    28. URIC ACID
    29. URINALYSIS
    30. VITAMIN B12

    INFECTIOUS DISEASE TESTS

    1. AIDS
    2. ADENOVIRUS
    3. CAMPYLOBACTER
    4. CANDIDA
    5. CHLAMYDIA
    6. CLOSTRIDIUM DIFFICILE
    7. CYTOMEGALOVIRUS
    8. ENTEROVIRUSES
    9. EPSTEIN-BARR VIRUS
    10. GONORRHEA
    11. HELICOBACTER PYLORI
    12. HEPATITIS
      a. Hepatitis A
      b. Hepatitis B
      c. Hepatitis C
      d. Hepatitis D
    13. HERPES SIMPLEX VIRUS
    14. HUMAN HERPES VIRUS-6 (HHV-6)
    15. INFLUENZA VIRUSES
    16. LEGIONELLA
    17. LYME DISEASE
    18. MEASLES (RUBEOLA)
    19. MENINGITIS
    20. MONONUCLEOSIS
    21. MUMPS
    22. MYCOPLASMA
    23. PAPILLOMAVIRUSES
    24. PNEUMONIA
    25. RESPIRATORY SYNCYTIAL VIRUS (RSV)
    26. RHEUMATOID ARTHRITIS
    27. ROTAVIRUS (REOVIRUS)
    28. RUBELLA (GERMAN MEASLES)
    29. SALMONELLOSIS
    30. SHIGELLOSIS
    31. STAPHYLOCOCCUS AUREUS
    32. STREPTOCOCCI
    33. SYPHILIS

    TUMOR MARKERS

    1. ALPHA-FETOPROTEIN (AFP)
    2. CARCINOEMBRIONIC ANTIGEN (CEA)
    3. OCCULT BLOOD
    4. PROSTATIC ACID PHOSPHATASE (PAP)
    5. PROSTATE-SPECIFIC ANTIGEN (PSA)

    MAJOR ROUTINE AND SPECIAL HEMATOLOGY TESTS

    1. CBC ANALYSIS
      a. Hemoglobin Concentration
      b. Hematocrit Determination
      c. Red Blood Cell Count
      d. Platelets

    ENDOCRINE FUNCTION TESTS

    1. CORTISOL
    2. FOLLICLE-STIMULATING HORMONE (FSH)
    3. GASTRIN
    4. HUMAN CHORIONIC GONADOTROPIN (HCG)
    5. LH
    6. PROLACTIN
    7. T3
    8. T3 UPTAKE
    9. FREE T3
    10. THYROXINE (T4)
    11. FREE T4
    12. TBG
    13. TSH

    THERAPEUTIC DRUG MONITORING (TDM)

    1. OVERVIEW
    2. CARBAMAZEPINE
    3. DIGOXIN
    4. GENTAMICIN
    5. LIDOCAINE
    6. LITHIUM
    7. PHENYTOIN/DILANTIN
    8. PROCAINAMIDE
    9. QUINIDINE
    10. THEOPHYLLINE
    11. VALPROIC ACID

    COAGULATION TESTS

    1. INTRODUCTION
    2. ACTIVATED PARTIAL THROMBOPLASTIN TIME (APTT)
    3. ALPHA-2 ANTIPLASMIN
    4. ANTITHROMBIN III
    5. BLEEDING TIME
    6. D-DIMER
    7. FACTOR VIII
    8. FIBRIN DEGRADATION PRODUCTS
    9. FIBRINOGEN
    10. HEPARIN
    11. PROTEINS C AND S
    12. PROTHROMBIN TIME (PT)
    13. THROMBIN TIME

    IMMUNOPROTEIN TESTS

    1. CRP
    2. IMMUNOGLOBULINS

    DRUGS OF ABUSE

    1. OVERVIEW
    2. TEST METHODOLOGIES
    3. AMPHETAMINES
    4. BARBITURATES
    5. BENZODIAZEPINES
    6. CANNABINOIDS/MARIJUANA
    7. COCAINE
    8. LYSERGIC ACID DIETHYLAMIDE (LSD)
    9. METHADONE
    10. METHAQUALONE
    11. OPIATES
    12. PHENCYCLIDINE

    INSTRUMENTATION

    1. CHEMISTRY ANALYZERS MANUFACTURED BY:
      Abaxis
      Abbott
      Alfa Wassermann
      Awareness Technologies
      Beckman Coulter/Danaher
      bioMeriuex
      Carolina Chemistries
      Horiba
      Inverness
      Medica
      Nova Biomedical
      Ortho-Clinical Diagnostics
      Polimedco
      Randox
      Roche
    2. HEMATOLOGY ANALYZERS MANUFACTURED BY:
      Abbott
      Becton Dickinson
      Beckman Coulter/Danaher
      Biocode
      Drew-Scientific
      Diesse Ves Matic
      Horiba
      Menarini
      Nihon Kohden
      Polymedco
      Sysmex
    3. COAGULATION ANALYZERS MANUFACTURED BY:
      Behnk Elektronik
      Bio/Data
      Cardiovascular Diagnostics
      Diagnostica Stago
      Helena Laboratories
      Instrumentation Laboratory
      ITC Hemochron
      Roche
      Siemens
      Sysmex
      Teco Medical Instruments
      Trinity Biotech

    CURRENT AND EMERGING TECHNOLOGIES

    1. MONOCLONAL ANTIBODIES
    2. IMMUNOASSAYS
      a. Technological Principle
      b. Enzyme Immunoassays (EIA)
        Overview
        ELISA
        Dot Immunobinding Assays
        Capillary Immunoassays
        Particle-Membrane Capture Immunoassay
        Enzyme Amplification
      c. Fluorescent Immunoassays
        Fluorescent Polarization
        Time-Resolved Pulse Fluorescence
      d. Luminescence
        Chemiluminescence
        Bioluminescence
      e. Latex Agglutination
      f. Immunoprecipitation
    3. DRY CHEMISTRY
    4. BIOSENSORS
    5. IT AND AUTOMATION
    6. MOLECULAR DIAGNOSTICS
      a. Technology Overview
      b. Amplification Methods
        Polymerase Chain Reaction
        Ligase Chain Reaction
        Branched DNA
        Q-Beta Replicase
        Strand Displacement Activation
        Self-Sustained Sequence Replicase

    WORLDWIDE BUSINESS ENVIRONMENT

    U.S.A. MARKET OVERVIEW

    1. BUSINESS ENVIRONMENT
      a. Health Care Expenditures
      b. Cost Consciousness
      c. Reimbursement
      d. Industry Consolidation
      e. Managed Care
        PPO
        HMO
      f. Hospitals
      g. Admissions
      h. Length of Stay
      i. Industry Diversification
      j. Physician Demographics
      k. Aging Population
        More Chronic Illness
        Disease Incidence
        Susceptibility to latrogenesis
        Multiple Illnesses Cases
      l. Laboratory Regulations
    2. MARKET STRUCTURE
      a. Hospitals
      b. Commercial/Private Laboratories

    ANCILLARY HOSPITAL LOCATIONS

    1. INTRODUCTION
      a. Emergency Departments
      b. Operating Suites
      c. Intensive Care Units
    2. EMERGENCY DEPARTMENTS
      a. Market Summary
      b. Test volume and Sales Forecasts
    3. OPERATING AND RECOVERY SUITES
      a. Market Summary
      b. Test Volume and Sales Forecasts
    4. ICUS/CCUS
      a. Market Summary
      b. Test Volume and Sales Forecasts

    MAJOR SUPPLIERS’ INSTRUMENT PLACEMENTS, INSTALLED BASE, CONSUMABLE SALES AND MARKET SHARES

    MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES

    A. Routine and Special Chemistry
    B. Microbiology/Infectious Diseases
    C. Hematology and Flow Cytometry
    D. Coagulation

    DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS

    ALTERNATIVE MARKET PENETRATION STRATEGIES

    A. Internal Development
    B. Collaborative Arrangements
    C. University Contracts
    D. Distribution Strategies for Decentralized Testing Markets
      1. MARKETING APPROACHES
      2. PRODUCT COMPLEXITY
      3. CUSTOMER PREFERENCE
      4. ESTABLISHED SUPPLIERS
      5. EMERGING SUPPLIERS
      6. MAJOR TYPES OF DISTRIBUTORS
      7. MARKET SEGMENTATION

    POTENTIAL MARKET ENTRY BARRIERS AND RISKS

    A. Market Maturity
    B. Cost Containment
    C. Competition
    D. Technological Edge and Limitations
    E. Patent Protection
    F. Regulatory Constraints
    G. Decentralized Testing Market Challenges

    COMPANY PROFILE

    Abbott
    ADI/American Diagnostica
    Agilent Technologies
    Alere/Biosite/Inverness
    Axis-Shield
    Beckman Coulter/Danaher
    Becton Dickinson
    Bio/Data
    Biomerieux
    Bio-Rad
    Cepheid
    Chrono-Log
    Corgenix
    Decode Genetics
    Diadexus
    Diagnocure
    Diagnostica Stago/Trinity Biotech
    Diamedix
    Diasorin
    Eiken Chemical
    EKF Diagnostics
    Fujirebio
    Grifols
    Helena Laboratories
    Hologic/Gen-Probe
    Horiba
    Instrumentation Laboratory
    International Technidyne/Nexus DX
    Kreatech/Leica
    Kyowa Medex
    Lonza
    Mackay Life Sciences
    Matritech
    Nihon Kohden
    Ortho-Clinical Diagnostics
    Polartechnics
    Polymedco
    Qiagen
    Roche
    SDIX
    Sequenom
    Siemens
    Sienco
    Sysmex
    Takara Bio
    ThermoFisher
    Tosoh
    Wako
    Zycare/Alere

    LIST OF TABLES

    Major Companies Developing or Marketing Albumin Tests
    Major Companies Developing or Marketing Alkaline Phosphatase Tests
    Major Companies Developing or Marketing ALT/SGPT Tests
    Major Companies Developing or Marketing Amylase Tests
    Major Companies Developing or Marketing AST/SGOT Tests
    Major Companies Developing or Marketing Bilirubin Tests
    Major Companies Developing or Marketing Blood Gas Analyzers
    Major Companies Developing or Marketing BUN Tests
    Major Companies Developing or Marketing Calcium Tests
    Major Companies Developing or Marketing Cholesterol Tests
    Major Companies Developing or Marketing Creatinine Tests
    Major Companies Developing or Marketing Electrolyte Tests
    Major Companies Developing or Marketing Ferritin Tests
    Major Companies Developing or Marketing GGT Tests
    Major Companies Developing or Marketing Glucose Tests
    Major Companies Developing or Marketing HDL Tests
    Major Companies Developing or Marketing Iron Tests
    Major Companies Developing or Marketing LDH Tests
    Major Companies Developing or Marketing Magnesium Tests
    Major Companies Developing or Marketing Phosphorus Tests
    Major Companies Developing or Marketing Protein Tests
    Major Companies Developing or Marketing Triglycerides Tests
    Major Companies Developing or Marketing Uric Acid Tests
    Major Companies Developing or Marketing Vitamin B-12/Folate Tests
    Major Companies Developing or Marketing AIDS Tests
    Major Companies Developing or Marketing Adenovirus Tests
    Major Companies Developing or Marketing Campylobacter Tests
    Major Companies Developing or Marketing Candida Tests
    Major Companies Developing or Marketing CMV Tests
    Major Companies Developing or Marketing EBV Tests
    Major Companies Developing or Marketing Gonorrhea Tests
    Major Companies Developing or Marketing Helicobacter Pylori Tests
    Major Companies Developing or Marketing Hepatitis Tests
    Major Companies Developing or Marketing Herpes Tests
    Major Companies Developing or Marketing Influenza Tests
    Major Companies Developing or Marketing Legionella Tests
    Major Companies Developing or Marketing Lyme Disease Tests
    Major Companies Developing or Marketing Measles Tests
    Major Companies Developing or Marketing Meningitis Tests
    Major Companies Developing or Marketing Mononucleosis Tests
    Major Companies Developing or Marketing Mumps Tests
    Major Companies Developing or Marketing Mycoplasma Tests
    Major Companies Developing or Marketing Pneumonia Tests
    Major Companies Developing or Marketing RSV Tests
    Major Companies Developing or Marketing Rotavirus Tests
    Major Companies Developing or Marketing Rubella Tests
    Major Companies Developing or Marketing Salmonella Tests
    Major Companies Developing or Marketing Shigella Tests
    Major Companies Developing or Marketing Streptococci Tests
    Major Companies Developing or Marketing Syphilis Tests
    Major Companies Developing or Marketing AFP Tests
    Major Companies Developing or Marketing CEA Tests
    Major Companies Developing or Marketing Occult Blood Tests
    Major Companies Developing or Marketing Prostatic Acid Phosphatase Tests
    Major Companies Developing or Marketing PSA Tests
    Major Companies Developing or Marketing FSH Tests
    Major Companies Developing or Marketing HCG Tests
    Major Companies Developing or Marketing LH Tests
    Major Companies Developing or Marketing Prolactin Tests
    Major Companies Developing or Marketing T3 Tests
    Major Companies Developing or Marketing T4 Tests
    Major Companies Developing or Marketing TSH Tests
    Major Companies Developing or Marketing TDM Tests
    Major Companies Developing or Marketing Digoxin Tests
    Major Companies Developing or Marketing Lithium Tests
    Major Companies Developing or Marketing Phenytoin/Dilantin Tests
    Major Companies Developing or Marketing Theophylline Tests
    Major Companies Developing or Marketing Valproic Acid Tests
    Major Companies Developing or Marketing APTT Tests
    Major Companies Developing or Marketing Alpha-2 Antiplasmin Tests
    Major Companies Developing or Marketing Altithrombin III Tests
    Major Companies Developing or Marketing Bleeding Time Tests
    Major Companies Developing or Marketing D-Dimer Tests
    Major Companies Developing or Marketing Factor Assays Tests
    Major Companies Developing or Marketing Fibrin Degradation Product Tests
    Major Companies Developing or Marketing Fibrinogen Tests
    Major Companies Developing or Marketing Heparin Tests
    Major Companies Developing or Marketing Protein C Tests
    Major Companies Developing or Marketing Protein S Tests
    Major Companies Developing or Marketing PT Tests
    Major Companies Developing or Marketing Thrombin Time Tests
    Major Companies Developing or Marketing CRP Tests
    Major Companies Developing or Marketing Drugs of Abuse Tests
    Ancillary Hospital Locations Estimated Number
    Ancillary Hospital Locations Annual Utilization
    Hospital Emergency Departments Total Diagnostics Sales Forecast by Market Segment
    Hospital Emergency Departments Reagent Sales Forecast by Market Segment
    Hospital Emergency Departments Instrument Sales Forecast by Market Segment
    Hospital Emergency Departments Routine and Special Chemistry Test Volume Forecast
    Hospital Emergency Departments Profiles Panels and Individual Tests
    Hospital Emergency Departments Drugs of Abuse Test Volume Forecast
    Hospital Emergency Departments Routine Hematology Test Volume Forecast
    Hospital Emergency Departments Coagulation Test Volume Forecast
    Hospital Emergency Departments Selected Infectious Disease Test Volume Forecast
    Hospital Emergency Departments Routine and Special Chemistry Reagent Market Forecast by Test
    Hospital Emergency Departments Drugs of Abuse Reagent Market Forecast by Test
    Hospital Emergency Departments Hematology Reagent Market Forecast
    Hospital Emergency Departments Coagulation Reagent Market Forecast
    Hospital Emergency Departments Selected Infectious Disease Reagent Market Forecast by Test
    Hospital Operating and Recovery Suites Total Diagnostics Sales Forecast by Market Segment
    Hospital Operating and Recovery Suites Reagent Sales Forecast by Market Segment
    Hospital Operating and Recovery Suites Instrument Sales Forecast By Market Segment
    Hospital Operating and Recovery Suites Routine and Special Chemistry Reagent Test Volume Forecast
    Hospital Operating and Recovery Suites Routine Hematology Test Volume Forecast
    Hospital Operating and Recovery Suites Coagulation Test Volume Forecast
    Hospital Operating and Recovery Suites outine and Special Chemistry Reagent Market Forecast by Test
    Hospital Operating and Recovery Suites Hematology Reagent Market Forecast
    Hospital Operating and Recovery Suites Coagulation Reagent Market Forecast
    Hospital ICUs/CCUs Total Diagnostics Sales Forecast by Market Segment
    Hospital ICUs/CCUs Reagent Sales Forecast by Market Segment
    ICUs/CCUs Instrument Sales Forecast by Market Segment
    Hospital ICUs/CCUs Routine and Special Chemistry Test Volume Forecast
    Hospital ICUs/CCUs Routine Hematology Test Volume Forecast
    Hospital ICUs/CCUs Coagulation Test Volume Forecast
    Hospital ICUs/CCUs Routine and Special Chemistry Reagent Market Forecast by Test
    Hospital ICUs/CCUs Hematology Reagent Market Forecast
    Hospital ICUs/CCUs Coagulation Reagent Market Forecast
    Major Suppliers of Clinical Chemistry Diagnostic Products, Estimated Sales and Market Shares
    Major Suppliers of Clinical Chemistry Reagents, Estimated Sales and Market Shares
    Major Suppliers of Clinical Chemistry Analyzers, Estimated Sales and Market Shares
    Major Suppliers of Immunodiagnostic Products, Estimated Sales and Market Shares
    Major Suppliers of Immunoassay Reagents, Estimated Sales and Market Shares
    Major Suppliers of Immunoassay Analyzers, Estimated Sales and Market Shares
    AIDS Testing Market Estimated Market Shares of Major Suppliers
    Chlamydia Testing Market Estimated Market Shares of Major Suppliers
    CMV Testing Market Estimated Market Shares of Major Suppliers
    Gonorrhea Testing Market Estimated Market Shares of Major Suppliers
    Helicobacter Pylori Testing Market Estimated Market Shares of Major Suppliers
    Hepatitis Testing Market Estimated Market Shares of Major Suppliers
    Herpes Testing Market Estimated Market Shares of Major Suppliers
    Influenza Testing Market Estimated Market Shares of Major Suppliers
    Lyme Disease Testing Market Estimated Market Shares of Major Suppliers
    Mononucleosis Testing Market Estimated Market Shares of Major Suppliers
    Rubella Testing Market Estimated Market Shares of Major Suppliers
    Streptococci Testing Market Estimated Market Shares of Major Suppliers
    Syphilis Testing Market Estimated Market Shares of Major Suppliers
    AFP Testing Market by Major Supplier
    CA 15-3/27-29 Testing Market by Major Supplier
    CA 19-9 Testing Market by Major Supplier
    CEA Testing Market by Major Supplier
    PAP Testing Market by Major Supplier
    PSA Testing Market by Major Supplier
    Hematology Analyzers Estimated Placements and Installed Base
    Flow Cytometers Estimated Placements and Installed Base
    Hematology Diagnostics Market Estimated Market Shares of Major Suppliers
    Hematology Instrument Market Estimated Market Shares of Major Suppliers
    Hematology Consumable Market Estimated Market Shares of Major Suppliers
    Flow Cytometry Diagnostics Market Estimated Market Shares of Major Suppliers
    Flow Cytometry Consumable Market Estimated Market Shares of Major Suppliers
    Flow Cytometry Instrument Market Estimated Market Shares of Major Suppliers
    Major Suppliers of Coagulation Diagnostic Products, Estimated Market Shares of Major Suppliers


    More Publications